APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Plaque Psoriasis Treatment Medications

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Plaque Psoriasis Treatment Medications Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174026390328 December 2025194 pages

Choose your research edition.

Industry ResearchPlaque Psoriasis Treatment Medications Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Plaque Psoriasis Treatment Medications Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Plaque Psoriasis Treatment Medications Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Plaque Psoriasis Treatment Medications Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Plaque Psoriasis Treatment Medications Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global Plaque Psoriasis Treatment Medications market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Plaque Psoriasis Treatment Medications is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Plaque Psoriasis Treatment Medications is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Plaque Psoriasis Treatment Medications is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Plaque Psoriasis Treatment Medications is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Plaque Psoriasis Treatment Medications include Johnson & Johnson, Novartis, Merck, Eli Lilly, Pfizer, UCB, Organon, LEO Pharma and Galectin Therapeutics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Plaque Psoriasis Treatment Medications market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Plaque Psoriasis Treatment Medications and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Plaque Psoriasis Treatment Medications sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Plaque Psoriasis Treatment Medications market size, projected growth trends, production technologies, key applications, and end-use industries.

Plaque Psoriasis Treatment Medications Segment by Company

Johnson & Johnson

Novartis

Merck

Eli Lilly

Pfizer

UCB

Organon

LEO Pharma

Galectin Therapeutics

Dermira

Cellceutix

Biogen

Bayer

AstraZeneca

Amgen

Allergan

AbbVie

Plaque Psoriasis Treatment Medications Segment by Type

Non-biologic Drugs

Biologics

Small Molecule Drugs

Plaque Psoriasis Treatment Medications Segment by Application

Hospital

Clinic

Other

Plaque Psoriasis Treatment Medications Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plaque Psoriasis Treatment Medications market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Plaque Psoriasis Treatment Medications and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plaque Psoriasis Treatment Medications.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Plaque Psoriasis Treatment Medications market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Plaque Psoriasis Treatment Medications manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Plaque Psoriasis Treatment Medications in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Plaque Psoriasis Treatment Medications in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Plaque Psoriasis Treatment Medications Industry Trends Table 2. Plaque Psoriasis Treatment Medications Industry Drivers Table 3. Plaque Psoriasis Treatment Medications Industry Opportunities and Challenges Table 4. Plaque Psoriasis Treatment Medications Industry Restraints Table 5. Global Plaque Psoriasis Treatment Medications Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Plaque Psoriasis Treatment Medications Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Plaque Psoriasis Treatment Medications Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Plaque Psoriasis Treatment Medications Sales Market Share by Manufacturers Table 9. Global Plaque Psoriasis Treatment Medications Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Plaque Psoriasis Treatment Medications Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Plaque Psoriasis Treatment Medications Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Plaque Psoriasis Treatment Medications Manufacturers, Product Type & Application Table 13. Global Plaque Psoriasis Treatment Medications Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Plaque Psoriasis Treatment Medications by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Non-biologic Drugs Table 17. Major Manufacturers of Biologics Table 18. Major Manufacturers of Small Molecule Drugs Table 19. Global Plaque Psoriasis Treatment Medications Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Plaque Psoriasis Treatment Medications Sales by Type (2021-2026) & (K Units) Table 21. Global Plaque Psoriasis Treatment Medications Sales by Type (2027-2032) & (K Units) Table 22. Global Plaque Psoriasis Treatment Medications Sales Market Share by Type (2021-2026) Table 23. Global Plaque Psoriasis Treatment Medications Sales Market Share by Type (2027-2032) Table 24. Global Plaque Psoriasis Treatment Medications Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Plaque Psoriasis Treatment Medications Revenue by Type (2021-2026) & (K Units) Table 26. Global Plaque Psoriasis Treatment Medications Revenue by Type (2027-2032) & (K Units) Table 27. Global Plaque Psoriasis Treatment Medications Revenue Market Share by Type (2021-2026) Table 28. Global Plaque Psoriasis Treatment Medications Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Hospital Table 30. Major Manufacturers of Clinic Table 31. Major Manufacturers of Other Table 32. Global Plaque Psoriasis Treatment Medications Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Plaque Psoriasis Treatment Medications Sales by Application (2021-2026) & (K Units) Table 34. Global Plaque Psoriasis Treatment Medications Sales by Application (2027-2032) & (K Units) Table 35. Global Plaque Psoriasis Treatment Medications Sales Market Share by Application (2021-2026) Table 36. Global Plaque Psoriasis Treatment Medications Sales Market Share by Application (2027-2032) Table 37. Global Plaque Psoriasis Treatment Medications Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Plaque Psoriasis Treatment Medications Revenue by Application (2021-2026) & (K Units) Table 39. Global Plaque Psoriasis Treatment Medications Revenue by Application (2027-2032) & (K Units) Table 40. Global Plaque Psoriasis Treatment Medications Revenue Market Share by Application (2021-2026) Table 41. Global Plaque Psoriasis Treatment Medications Revenue Market Share by Application (2027-2032) Table 42. Global Plaque Psoriasis Treatment Medications Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Plaque Psoriasis Treatment Medications Sales by Region (2021-2026) & (K Units) Table 44. Global Plaque Psoriasis Treatment Medications Sales Market Share by Region (2021-2026) Table 45. Global Plaque Psoriasis Treatment Medications Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Plaque Psoriasis Treatment Medications Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Plaque Psoriasis Treatment Medications Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Plaque Psoriasis Treatment Medications Sales by Country (2021-2026) & (K Units) Table 49. North America Plaque Psoriasis Treatment Medications Sales by Country (2027-2032) & (K Units) Table 50. Europe Plaque Psoriasis Treatment Medications Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Plaque Psoriasis Treatment Medications Sales by Country (2021-2026) & (K Units) Table 52. Europe Plaque Psoriasis Treatment Medications Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Plaque Psoriasis Treatment Medications Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Plaque Psoriasis Treatment Medications Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Plaque Psoriasis Treatment Medications Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Plaque Psoriasis Treatment Medications Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Plaque Psoriasis Treatment Medications Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Plaque Psoriasis Treatment Medications Sales by Country (2027-2032) & (K Units) Table 59. Global Plaque Psoriasis Treatment Medications Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Plaque Psoriasis Treatment Medications Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Plaque Psoriasis Treatment Medications Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Plaque Psoriasis Treatment Medications Revenue Market Share by Region (2021-2026) Table 63. Global Plaque Psoriasis Treatment Medications Revenue Market Share by Region (2027-2032) Table 64. Johnson & Johnson Company Information Table 65. Johnson & Johnson Business Overview Table 66. Johnson & Johnson Plaque Psoriasis Treatment Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Johnson & Johnson Plaque Psoriasis Treatment Medications Product Portfolio Table 68. Johnson & Johnson Recent Development Table 69. Novartis Company Information Table 70. Novartis Business Overview Table 71. Novartis Plaque Psoriasis Treatment Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Novartis Plaque Psoriasis Treatment Medications Product Portfolio Table 73. Novartis Recent Development Table 74. Merck Company Information Table 75. Merck Business Overview Table 76. Merck Plaque Psoriasis Treatment Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Merck Plaque Psoriasis Treatment Medications Product Portfolio Table 78. Merck Recent Development Table 79. Eli Lilly Company Information Table 80. Eli Lilly Business Overview Table 81. Eli Lilly Plaque Psoriasis Treatment Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Eli Lilly Plaque Psoriasis Treatment Medications Product Portfolio Table 83. Eli Lilly Recent Development Table 84. Pfizer Company Information Table 85. Pfizer Business Overview Table 86. Pfizer Plaque Psoriasis Treatment Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Pfizer Plaque Psoriasis Treatment Medications Product Portfolio Table 88. Pfizer Recent Development Table 89. UCB Company Information Table 90. UCB Business Overview Table 91. UCB Plaque Psoriasis Treatment Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. UCB Plaque Psoriasis Treatment Medications Product Portfolio Table 93. UCB Recent Development Table 94. Organon Company Information Table 95. Organon Business Overview Table 96. Organon Plaque Psoriasis Treatment Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Organon Plaque Psoriasis Treatment Medications Product Portfolio Table 98. Organon Recent Development Table 99. LEO Pharma Company Information Table 100. LEO Pharma Business Overview Table 101. LEO Pharma Plaque Psoriasis Treatment Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. LEO Pharma Plaque Psoriasis Treatment Medications Product Portfolio Table 103. LEO Pharma Recent Development Table 104. Galectin Therapeutics Company Information Table 105. Galectin Therapeutics Business Overview Table 106. Galectin Therapeutics Plaque Psoriasis Treatment Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Galectin Therapeutics Plaque Psoriasis Treatment Medications Product Portfolio Table 108. Galectin Therapeutics Recent Development Table 109. Dermira Company Information Table 110. Dermira Business Overview Table 111. Dermira Plaque Psoriasis Treatment Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Dermira Plaque Psoriasis Treatment Medications Product Portfolio Table 113. Dermira Recent Development Table 114. Cellceutix Company Information Table 115. Cellceutix Business Overview Table 116. Cellceutix Plaque Psoriasis Treatment Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Cellceutix Plaque Psoriasis Treatment Medications Product Portfolio Table 118. Cellceutix Recent Development Table 119. Biogen Company Information Table 120. Biogen Business Overview Table 121. Biogen Plaque Psoriasis Treatment Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Biogen Plaque Psoriasis Treatment Medications Product Portfolio Table 123. Biogen Recent Development Table 124. Bayer Company Information Table 125. Bayer Business Overview Table 126. Bayer Plaque Psoriasis Treatment Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Bayer Plaque Psoriasis Treatment Medications Product Portfolio Table 128. Bayer Recent Development Table 129. AstraZeneca Company Information Table 130. AstraZeneca Business Overview Table 131. AstraZeneca Plaque Psoriasis Treatment Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. AstraZeneca Plaque Psoriasis Treatment Medications Product Portfolio Table 133. AstraZeneca Recent Development Table 134. Amgen Company Information Table 135. Amgen Business Overview Table 136. Amgen Plaque Psoriasis Treatment Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. Amgen Plaque Psoriasis Treatment Medications Product Portfolio Table 138. Amgen Recent Development Table 139. Allergan Company Information Table 140. Allergan Business Overview Table 141. Allergan Plaque Psoriasis Treatment Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 142. Allergan Plaque Psoriasis Treatment Medications Product Portfolio Table 143. Allergan Recent Development Table 144. AbbVie Company Information Table 145. AbbVie Business Overview Table 146. AbbVie Plaque Psoriasis Treatment Medications Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 147. AbbVie Plaque Psoriasis Treatment Medications Product Portfolio Table 148. AbbVie Recent Development Table 149. Key Raw Materials Table 150. Raw Materials Key Suppliers Table 151. Plaque Psoriasis Treatment Medications Distributors List Table 152. Plaque Psoriasis Treatment Medications Customers List Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources Table 156. Primary Sources List of Figures Figure 1. Plaque Psoriasis Treatment Medications Product Image Figure 2. Global Plaque Psoriasis Treatment Medications Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Plaque Psoriasis Treatment Medications Market Size (2021-2032) & (US$ Million) Figure 4. Global Plaque Psoriasis Treatment Medications Sales (2021-2032) & (K Units) Figure 5. Global Plaque Psoriasis Treatment Medications Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Plaque Psoriasis Treatment Medications Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Non-biologic Drugs Image Figure 9. Biologics Image Figure 10. Small Molecule Drugs Image Figure 11. Global Plaque Psoriasis Treatment Medications Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Plaque Psoriasis Treatment Medications Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Plaque Psoriasis Treatment Medications Sales Market Share by Type (2021-2032) Figure 14. Global Plaque Psoriasis Treatment Medications Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Plaque Psoriasis Treatment Medications Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Plaque Psoriasis Treatment Medications Revenue Market Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Other Image Figure 20. Global Plaque Psoriasis Treatment Medications Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Plaque Psoriasis Treatment Medications Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Plaque Psoriasis Treatment Medications Sales Market Share by Application (2021-2032) Figure 23. Global Plaque Psoriasis Treatment Medications Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Plaque Psoriasis Treatment Medications Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Plaque Psoriasis Treatment Medications Revenue Market Share by Application (2021-2032) Figure 26. North America Plaque Psoriasis Treatment Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Plaque Psoriasis Treatment Medications Sales Market Share by Country (2021-2032) Figure 28. U.S. Plaque Psoriasis Treatment Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Plaque Psoriasis Treatment Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Plaque Psoriasis Treatment Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Plaque Psoriasis Treatment Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Plaque Psoriasis Treatment Medications Sales Market Share by Country (2021-2032) Figure 33. Germany Plaque Psoriasis Treatment Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Plaque Psoriasis Treatment Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Plaque Psoriasis Treatment Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Plaque Psoriasis Treatment Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Plaque Psoriasis Treatment Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Plaque Psoriasis Treatment Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Plaque Psoriasis Treatment Medications Sales Market Share by Country (2021-2032) Figure 40. China Plaque Psoriasis Treatment Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Plaque Psoriasis Treatment Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Plaque Psoriasis Treatment Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Plaque Psoriasis Treatment Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Plaque Psoriasis Treatment Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Plaque Psoriasis Treatment Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Plaque Psoriasis Treatment Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Plaque Psoriasis Treatment Medications Sales Market Share by Country (2021-2032) Figure 48. Brazil Plaque Psoriasis Treatment Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Plaque Psoriasis Treatment Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Plaque Psoriasis Treatment Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Plaque Psoriasis Treatment Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Plaque Psoriasis Treatment Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Plaque Psoriasis Treatment Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Plaque Psoriasis Treatment Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Plaque Psoriasis Treatment Medications Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Plaque Psoriasis Treatment Medications Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Plaque Psoriasis Treatment Medications Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Plaque Psoriasis Treatment Medications Revenue (2021-2032) & (US$ Million) Figure 59. North America Plaque Psoriasis Treatment Medications Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Plaque Psoriasis Treatment Medications Revenue (2021-2032) & (US$ Million) Figure 61. Europe Plaque Psoriasis Treatment Medications Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Plaque Psoriasis Treatment Medications Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Plaque Psoriasis Treatment Medications Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Plaque Psoriasis Treatment Medications Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Plaque Psoriasis Treatment Medications Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Plaque Psoriasis Treatment Medications Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Plaque Psoriasis Treatment Medications Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Non-biologic Drugs
  • Biologics
  • Small Molecule Drugs
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Johnson & Johnson
  • Novartis
  • Merck
  • Eli Lilly
  • Pfizer
  • UCB
  • Organon
  • LEO Pharma
  • Galectin Therapeutics
  • Dermira
  • Cellceutix
  • Biogen
  • Bayer
  • AstraZeneca
  • Amgen
  • Allergan
  • AbbVie

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Plaque Psoriasis Treatment Medications Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Plaque Psoriasis Treatment Medications Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Plaque Psoriasis Treatment Medications Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Plaque Psoriasis Treatment Medications Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Plaque Psoriasis Treatment Medications Market Dynamics
  1. 2.1 Plaque Psoriasis Treatment Medications Industry Trends
  2. 2.2 Plaque Psoriasis Treatment Medications Industry Drivers
  3. 2.3 Plaque Psoriasis Treatment Medications Industry Opportunities and Challenges
  4. 2.4 Plaque Psoriasis Treatment Medications Industry Restraints
3 Plaque Psoriasis Treatment Medications Market by Manufacturers
  1. 3.1 Global Plaque Psoriasis Treatment Medications Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Plaque Psoriasis Treatment Medications Sales by Manufacturers (2021-2026)
  3. 3.3 Global Plaque Psoriasis Treatment Medications Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Plaque Psoriasis Treatment Medications Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Plaque Psoriasis Treatment Medications Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Plaque Psoriasis Treatment Medications Manufacturers, Product Type & Application
  7. 3.7 Global Plaque Psoriasis Treatment Medications Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Plaque Psoriasis Treatment Medications Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Plaque Psoriasis Treatment Medications Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Plaque Psoriasis Treatment Medications Tier 1, Tier 2, and Tier 3
4 Plaque Psoriasis Treatment Medications Market by Type
  1. 4.1 Plaque Psoriasis Treatment Medications Type Introduction
  2. 4.1.1 Non-biologic Drugs
  3. 4.1.2 Biologics
  4. 4.1.3 Small Molecule Drugs
  5. 4.2 Global Plaque Psoriasis Treatment Medications Sales by Type
  6. 4.2.1 Global Plaque Psoriasis Treatment Medications Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Plaque Psoriasis Treatment Medications Sales by Type (2021-2032)
  8. 4.2.3 Global Plaque Psoriasis Treatment Medications Sales Market Share by Type (2021-2032)
  9. 4.3 Global Plaque Psoriasis Treatment Medications Revenue by Type
  10. 4.3.1 Global Plaque Psoriasis Treatment Medications Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Plaque Psoriasis Treatment Medications Revenue by Type (2021-2032)
  12. 4.3.3 Global Plaque Psoriasis Treatment Medications Revenue Market Share by Type (2021-2032)
5 Plaque Psoriasis Treatment Medications Market by Application
  1. 5.1 Plaque Psoriasis Treatment Medications Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Plaque Psoriasis Treatment Medications Sales by Application
  6. 5.2.1 Global Plaque Psoriasis Treatment Medications Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Plaque Psoriasis Treatment Medications Sales by Application (2021-2032)
  8. 5.2.3 Global Plaque Psoriasis Treatment Medications Sales Market Share by Application (2021-2032)
  9. 5.3 Global Plaque Psoriasis Treatment Medications Revenue by Application
  10. 5.3.1 Global Plaque Psoriasis Treatment Medications Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Plaque Psoriasis Treatment Medications Revenue by Application (2021-2032)
  12. 5.3.3 Global Plaque Psoriasis Treatment Medications Revenue Market Share by Application (2021-2032)
6 Global Plaque Psoriasis Treatment Medications Sales by Region
  1. 6.1 Global Plaque Psoriasis Treatment Medications Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Plaque Psoriasis Treatment Medications Sales by Region (2021-2032)
  3. 6.2.1 Global Plaque Psoriasis Treatment Medications Sales by Region (2021-2026)
  4. 6.2.2 Global Plaque Psoriasis Treatment Medications Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Plaque Psoriasis Treatment Medications Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Plaque Psoriasis Treatment Medications Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Plaque Psoriasis Treatment Medications Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Plaque Psoriasis Treatment Medications Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Plaque Psoriasis Treatment Medications Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Plaque Psoriasis Treatment Medications Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Plaque Psoriasis Treatment Medications Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Plaque Psoriasis Treatment Medications Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Plaque Psoriasis Treatment Medications Revenue by Region
  1. 7.1 Global Plaque Psoriasis Treatment Medications Revenue by Region
  2. 7.1.1 Global Plaque Psoriasis Treatment Medications Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Plaque Psoriasis Treatment Medications Revenue by Region (2021-2026)
  4. 7.1.3 Global Plaque Psoriasis Treatment Medications Revenue by Region (2027-2032)
  5. 7.1.4 Global Plaque Psoriasis Treatment Medications Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Plaque Psoriasis Treatment Medications Revenue (2021-2032)
  8. 7.2.2 North America Plaque Psoriasis Treatment Medications Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Plaque Psoriasis Treatment Medications Revenue (2021-2032)
  11. 7.3.2 Europe Plaque Psoriasis Treatment Medications Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Plaque Psoriasis Treatment Medications Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Plaque Psoriasis Treatment Medications Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Plaque Psoriasis Treatment Medications Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Plaque Psoriasis Treatment Medications Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Johnson & Johnson
  2. 8.1.1 Johnson & Johnson Company Information
  3. 8.1.2 Johnson & Johnson Business Overview
  4. 8.1.3 Johnson & Johnson Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Johnson & Johnson Plaque Psoriasis Treatment Medications Product Portfolio
  6. 8.1.5 Johnson & Johnson Recent Developments
  7. 8.2 Novartis
  8. 8.2.1 Novartis Company Information
  9. 8.2.2 Novartis Business Overview
  10. 8.2.3 Novartis Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Novartis Plaque Psoriasis Treatment Medications Product Portfolio
  12. 8.2.5 Novartis Recent Developments
  13. 8.3 Merck
  14. 8.3.1 Merck Company Information
  15. 8.3.2 Merck Business Overview
  16. 8.3.3 Merck Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Merck Plaque Psoriasis Treatment Medications Product Portfolio
  18. 8.3.5 Merck Recent Developments
  19. 8.4 Eli Lilly
  20. 8.4.1 Eli Lilly Company Information
  21. 8.4.2 Eli Lilly Business Overview
  22. 8.4.3 Eli Lilly Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Eli Lilly Plaque Psoriasis Treatment Medications Product Portfolio
  24. 8.4.5 Eli Lilly Recent Developments
  25. 8.5 Pfizer
  26. 8.5.1 Pfizer Company Information
  27. 8.5.2 Pfizer Business Overview
  28. 8.5.3 Pfizer Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Pfizer Plaque Psoriasis Treatment Medications Product Portfolio
  30. 8.5.5 Pfizer Recent Developments
  31. 8.6 UCB
  32. 8.6.1 UCB Company Information
  33. 8.6.2 UCB Business Overview
  34. 8.6.3 UCB Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 UCB Plaque Psoriasis Treatment Medications Product Portfolio
  36. 8.6.5 UCB Recent Developments
  37. 8.7 Organon
  38. 8.7.1 Organon Company Information
  39. 8.7.2 Organon Business Overview
  40. 8.7.3 Organon Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Organon Plaque Psoriasis Treatment Medications Product Portfolio
  42. 8.7.5 Organon Recent Developments
  43. 8.8 LEO Pharma
  44. 8.8.1 LEO Pharma Company Information
  45. 8.8.2 LEO Pharma Business Overview
  46. 8.8.3 LEO Pharma Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 LEO Pharma Plaque Psoriasis Treatment Medications Product Portfolio
  48. 8.8.5 LEO Pharma Recent Developments
  49. 8.9 Galectin Therapeutics
  50. 8.9.1 Galectin Therapeutics Company Information
  51. 8.9.2 Galectin Therapeutics Business Overview
  52. 8.9.3 Galectin Therapeutics Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Galectin Therapeutics Plaque Psoriasis Treatment Medications Product Portfolio
  54. 8.9.5 Galectin Therapeutics Recent Developments
  55. 8.10 Dermira
  56. 8.10.1 Dermira Company Information
  57. 8.10.2 Dermira Business Overview
  58. 8.10.3 Dermira Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Dermira Plaque Psoriasis Treatment Medications Product Portfolio
  60. 8.10.5 Dermira Recent Developments
  61. 8.11 Cellceutix
  62. 8.11.1 Cellceutix Company Information
  63. 8.11.2 Cellceutix Business Overview
  64. 8.11.3 Cellceutix Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Cellceutix Plaque Psoriasis Treatment Medications Product Portfolio
  66. 8.11.5 Cellceutix Recent Developments
  67. 8.12 Biogen
  68. 8.12.1 Biogen Company Information
  69. 8.12.2 Biogen Business Overview
  70. 8.12.3 Biogen Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Biogen Plaque Psoriasis Treatment Medications Product Portfolio
  72. 8.12.5 Biogen Recent Developments
  73. 8.13 Bayer
  74. 8.13.1 Bayer Company Information
  75. 8.13.2 Bayer Business Overview
  76. 8.13.3 Bayer Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Bayer Plaque Psoriasis Treatment Medications Product Portfolio
  78. 8.13.5 Bayer Recent Developments
  79. 8.14 AstraZeneca
  80. 8.14.1 AstraZeneca Company Information
  81. 8.14.2 AstraZeneca Business Overview
  82. 8.14.3 AstraZeneca Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 AstraZeneca Plaque Psoriasis Treatment Medications Product Portfolio
  84. 8.14.5 AstraZeneca Recent Developments
  85. 8.15 Amgen
  86. 8.15.1 Amgen Company Information
  87. 8.15.2 Amgen Business Overview
  88. 8.15.3 Amgen Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Amgen Plaque Psoriasis Treatment Medications Product Portfolio
  90. 8.15.5 Amgen Recent Developments
  91. 8.16 Allergan
  92. 8.16.1 Allergan Company Information
  93. 8.16.2 Allergan Business Overview
  94. 8.16.3 Allergan Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Allergan Plaque Psoriasis Treatment Medications Product Portfolio
  96. 8.16.5 Allergan Recent Developments
  97. 8.17 AbbVie
  98. 8.17.1 AbbVie Company Information
  99. 8.17.2 AbbVie Business Overview
  100. 8.17.3 AbbVie Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 AbbVie Plaque Psoriasis Treatment Medications Product Portfolio
  102. 8.17.5 AbbVie Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Plaque Psoriasis Treatment Medications Value Chain Analysis
  2. 9.1.1 Plaque Psoriasis Treatment Medications Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Plaque Psoriasis Treatment Medications Production Mode & Process
  6. 9.2 Plaque Psoriasis Treatment Medications Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Plaque Psoriasis Treatment Medications Distributors
  9. 9.2.3 Plaque Psoriasis Treatment Medications Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst